Riskpilot← Back to searchSign inGet full accessSilvacura AB
ABActiveOrg 5592272479Kungsholmsgatan 12Hospital activities · NACE 8610Est. 20190 employees
Revenue 2025
SEK 56K
+30% vs 2024
EBITDA margin
78.1%
+41% vs 2024
Equity ratio
90.1%
Financial strength
Net profit 2025
SEK 35K
+37% vs 2024
| Revenue | SEK 56K | +30% |
| EBITDA | SEK 44K | +41% |
| Net profit | SEK 35K | +37% |
| Total assets | SEK 324K | +17% |
| Equity | SEK 292K | +14% |
| Employees | 0 | — |
Legal name
Silvacura AB
Org number
5592272479
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
18 november 2019
Share capital
SEK 50 400
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets huvudsakliga verksamhet är att bedriva föreläsningar och arbeta som instruktör inom området medicin och fysiologi, samt uthyrning av läkartjänst sk hyrläkare. Bolaget kommer även bedriva verksamhet inom området växtförädling för framtagande av nya köldtåligare grönsakssorter. Bolaget ska kunna äga och förvalta fast och lös egendom.
Address
Kungsholmsgatan 12
Email
johan.l.nordstrom@sll.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 146 | 26 | 50 | 43 | 56 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | 124 | 11 | 38 | 31 | 44 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 124 | 11 | 38 | 31 | 44 |
| Net financials | — | −0 | 1 | 1 | 1 |
| Profit before tax | 124 | 11 | 39 | 32 | 44 |
| Tax | −26 | −2 | −8 | −7 | −9 |
| Net profit | 98 | 9 | 31 | 26 | 35 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 261 | 226 | 252 | 276 | 324 |
| Equity | 191 | 200 | 231 | 257 | 292 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 70 | 26 | 22 | 20 | 32 |
| Total debt | 70 | 26 | 22 | 20 | 32 |
EBITDA margin
78.1%
This company
15.8%
Market median
+394% vs market
20212025
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
12.1%
This company
18.4%
Market median
+34% vs market
20212025
Net profit margin
63.2%
This company
8.1%
Market median
+680% vs market
20212025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Silvacura AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann-Christine Viveca Nordström | Deputy Board Member | 0 companies |
| Ebba Gitten Nordström | Deputy Board Member | 0 companies |
| Lars Johan Gottfrid Nordström | Board of Directors | 0 companies |